The predictive power of MDSC count may be more relevant when considered together with another parameter of immune function; in a cohort of elderly breast cancer patients, the presence of reduced levels of m-MDSC and a positive CD8+ T cell response to TAA conferred a 100% probability of survival at 4 years [91]. The gene discussed is CD8A; the disease is breast carcinoma.